TrialPloS one2016

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection.

Jesper Waldenström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.